Perbedaan Organon Pharma Indonesia Tbk. dan Siantar Top Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Siantar Top Tbk. diperdagangkan di Rp9.450 (kapitalisasi pasar 12,31 T, volume 24 jam 1 rb). Perbedaan utamanya: Siantar Top Tbk. jauh lebih besar — sekitar 117,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | STTP | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 12,31 T |
Volume | — | 1 rb |
Lot | — | 10 |
Perputaran | — | 9,47 jt |
Harga Rata-rata | — | 9.470 |
Nilai Transaksi | — | 9,47 jt |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT. Siantar Top Tbk (the Entity) was established based on Notarial Deed No. 45 dated May 12 1987 of Mrs. Endang Widjajanti, S.H., notary in Sidoarjo and was amended based on Notarial Deed No. 64 dated March 24, 1988 of the same notary.
Selengkapnya di halaman STTP →